Full-Time

Machine Learning Engineer

Posted on 2/1/2022

Reverie Labs

Reverie Labs

1-10 employees

Computational drug discovery for cancer therapies

No salary listed

Cambridge, MA, USA

Category
AI & Machine Learning
Required Skills
Python
Tensorflow
Pytorch
Data Analysis
Requirements
  • Deep Learning: Experience building CNNs, RNNs, etc. from scratch in a modern deep learning framework (Tensorflow, PyTorch, Caffe, etc.)
  • Classical ML: Experience with non-neural network deep learning models (random forests, SVM, etc.) and basic statistics
  • Data Engineering: Experience building large-scale data processing pipelines feeding into and analyzing results from ML
  • Experience with software development in Python
  • BS/MS/PhD in Computer Science or a related field, or strong machine learning experience

Reverie Labs uses computational drug discovery to speed up cancer therapy development by partnering with pharmaceutical and biotech firms to identify and optimize drug candidates. Their approach blends machine learning, cheminformatics, physics, biology, and chemistry to build models and workflows that search chemical space and guide chemistry decisions. They differentiate themselves through an interdisciplinary team delivering practical, collaborative drug discovery programs, as shown by partnerships such as Roche/Genentech. The goal is to accelerate bringing cancer therapies to clinical trials by providing computational tools and collaborative programs that streamline discovery and optimization.

Company Size

1-10

Company Stage

Series A

Total Funding

$25.1M

Headquarters

Cambridge, Massachusetts

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Ginkgo acquired Reverie’s AI infrastructure on February 28, 2024.
  • Four key AI team members joined Ginkgo to boost drug discovery.
  • Custom ML models excel in potency and ADME/PK predictions.

What critics are saying

  • Ginkgo acquisition stripped Reverie’s core AI platform and team.
  • Roche and Genentech terminated kinase inhibitor collaboration.
  • Insitro’s superior ML models poach Reverie’s pharma partners.

What makes Reverie Labs unique

  • Reverie Labs applies machine learning to lead generation and optimization.
  • Developed multi-objective optimizer using evolutionary algorithms for ADME/PK.
  • Engineers brain-penetrant kinase inhibitors for cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Reverie Labs who can refer or advise you

Company News

BiopharmaTrend
Mar 16th, 2024
A Busy Day for Ginkgo Bioworks

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

VentureBeat
Feb 3rd, 2021
Reverie Labs raises $25 million for its AI drug discovery platform

Reverie Labs, a company leveraging AI for drug discovery, has raised $25 million in venture capital funding.Read More

SynBioBeta
Aug 30th, 2020
A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain

By zeroing in on a notorious class of enzymes associated with cancer, Reverie Labs puts the power of cloud computing to its full potential Can two smart, motivated college grads start a pharmaceutical company in an apartment with a few laptops? Just ask Jonah Kallenbach and Ankit Gupta, co-founders of Reverie Labs. Based in Cambridge, Reverie Labs is applying […]

INACTIVE